flash news

Early on October 2, 2020, U.S. President Donald Trump, 74, revealed that he had tested positive for the novel corona virus. A day earlier, he had tested positive on a rapid test used for screening White House staff , which was later confirmed by a more accurate lab test. He …

Neuralink Corporation is a neuro technology company founded by Elon Musk and others in 2016 with its headquarters in San Francisco. Its team of extraordinarily talented scientists is working to develop a fully integrated brain machine interface (BMI) system—sometimes called a brain computer interface (BCI)—that enables a computer (or other …

In the United States, Operation Warp Speed (OWS) is a collaboration of several US government departments, including Health and Human Services, and the private sector. Through it, the National Institutes of Health (NIH) has entered into collaboration with 18 bio pharmaceutical companies to accelerate development of drugs and vaccines to …

Director General Balram Bhargava of the Indian Council of Medical Research (ICMR) has announced that Phase 2 clinical trials of two indigenously developed COVID-19 vaccines have been almost completed. India has two indigenous vaccine candidates—ZyCOV-D by Zydus Cadila and Covaxin by Bharat Biotech. He said that while final trials normally …

The United Kingdom’s Royal College of Pathologists has called for more stringent rules on kits sold directly to consumers, warning that they can “mislead the public and put individuals at risk”. They say that the tests should be used with professional back-up and should give the right results that are …

Backtracking on his earlier suggestion to make COVID-19 vaccination mandatory for all, the Australian prime minister has clarified, “There are no compulsory vaccines in Australia,” and that there will be “no compulsory vaccine, but there will be a lot of encouragement and measures to get as high a rate of …

According to Japanese health minister Katsunobu Kato, British company AstraZeneca Plc will supply 120 million doses of its vaccine being developed with the University of Oxford. The first tranche of 30 million doses will be received in March, 2021. AstraZeneca is conducting the final-stage clinical trial of its experimental AZD1222 …

The Wuhan Institute of Biological Products has announced that its COVID-19 vaccine will be commercially available by the end of December, 2020. Chinese vaccine manufacturer Sinopharm CNBG has begun conducting Phase 3 clinical trials of the vaccine in thousands of human volunteers, after it was found to provoke strong antibody …

President Vladimir Putin has announced that Russia’s health ministry has granted regulatory approval for Phase 3 clinical trials of the Sputnik V vaccine, which will begin very shortly, with tens of thousands of people in the Moscow region being vaccinated to gauge its efficacy and safety. In doing so, Russia …